These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22541601)

  • 21. Effect of a pocket-size tablet-dispensing device on glycaemic control in Type 2 diabetic patients.
    Maier C; Mustapic D; Schuster E; Luger A; Eher R
    Diabet Med; 2006 Jan; 23(1):40-5. PubMed ID: 16409564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
    Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].
    Perusicová J; Haladová I; Pit'hová P; Acsová D; Belobrádková J; Belzová A; Berková K; Dolezalová B; Dvoráková H; Hejnicová K; Hudcová M; Kallmünzerová D; Krejsová Z; Markofová G; Müllerová H; Owen K; Pelikánová M; Raclavská L; Racická E; Skarpová O; Váchová A; Veselá A; Vyoralos J; Broz J; Edelsberger T; Honka M; Hrdina T; Chmura P; Tosovský J
    Vnitr Lek; 2013 Mar; 59(3):165-71. PubMed ID: 23713182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of casual postprandial glucose levels in type 2 diabetes management.
    El-Kebbi IM; Ziemer DC; Cook CB; Gallina DL; Barnes CS; Phillips LS
    Diabetes Care; 2004 Feb; 27(2):335-9. PubMed ID: 14747210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
    Müller N; Kloos C; Frank T; Ristow M; Wolf G; Müller UA
    Diabet Med; 2011 Feb; 28(2):223-6. PubMed ID: 21219434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff.
    Baldwin D; Villanueva G; McNutt R; Bhatnagar S
    Diabetes Care; 2005 May; 28(5):1008-11. PubMed ID: 15855558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus.
    Bosi E; Dotta F; Jia Y; Goodman M
    Diabetes Obes Metab; 2009 May; 11(5):506-15. PubMed ID: 19320662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.
    Guerci B; Drouin P; Grangé V; Bougnères P; Fontaine P; Kerlan V; Passa P; Thivolet Ch; Vialettes B; Charbonnel B;
    Diabetes Metab; 2003 Dec; 29(6):587-94. PubMed ID: 14707887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes.
    Aschner P; Katzeff HL; Guo H; Sunga S; Williams-Herman D; Kaufman KD; Goldstein BJ;
    Diabetes Obes Metab; 2010 Mar; 12(3):252-61. PubMed ID: 20070351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom.
    Sterzi D; Auziere S; Glah D; Markert Jensen M
    Prim Care Diabetes; 2017 Jun; 11(3):241-247. PubMed ID: 28395938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for insulin initiation: insights from the French LIGHT observational study.
    Vergès B; Brun JM; Tawil C; Alexandre B; Kerlan V
    Diabetes Metab Res Rev; 2012 Jan; 28(1):97-105. PubMed ID: 22218757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
    Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
    Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE).
    Mathieu C; Barnett AH; Brath H; Conget I; de Castro JJ; Göke R; Márquez Rodriguez E; Nilsson PM; Pagkalos E; Penfornis A; Schaper NC; Wangnoo SK; Kothny W; Bader G
    Int J Clin Pract; 2013 Oct; 67(10):947-56. PubMed ID: 23961850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug titration patterns and HbA 1c levels in type 2 diabetes.
    Maclean JR; Chapman RH; Ferrufino CP; Krishnarajah G
    Int J Clin Pract; 2009 Jul; 63(7):1008-16. PubMed ID: 19570118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.
    Eliasson B; Eeg-Olofsson K; Cederholm J; Nilsson PM; Gudbjörnsdóttir S;
    Diabetes Metab; 2007 Sep; 33(4):269-76. PubMed ID: 17499541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study.
    Owens DR; Luzio SD; Sert-Langeron C; Riddle MC
    Diabetes Obes Metab; 2011 Nov; 13(11):1020-7. PubMed ID: 21679291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.